Target intelligence / Profile preview

Immunoglobulin lambda variable 3-19 (IGLV3-19)

Target
IGLV3-19
Molecular classification
Immunoglobulin variable region, Antigen-binding domain, Immunoglobulin light chain segment
01

Overview

Immunoglobulin lambda variable 3-19 is a gene encoding the variable region of the lambda chain of immunoglobulins (antibody molecules). This segment contributes to the formation of the antigen-binding site in antibodies, which is essential for the specific recognition of pathogens and initiation of adaptive immune responses. As part of the variable domain, IGLV3-19 undergoes V(D)J recombination in B cells, providing diversity to the antibody repertoire through somatic hypermutation and affinity maturation. The protein is secreted as part of immunoglobulin molecules produced by B lymphocytes and operates extracellularly, enabling effective elimination of antigens during the humoral immune response

Other names
Ig lambda chain V-III region SHIGLV319V2-13VL3Lrearranged Vl3l gene segmentrearranged Vl3l segment
02

Biological functions

Antigen recognitionImmune responseEffector phase of humoral immunity
03

Disease associations

Associated with immune regulation disorders and rare associations such as Autism Spectrum Disorder (by gene localization, not pathogenic mutation)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 3-19 (IGLV3-19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 3-19 (IGLV3-19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call